TACSTD2 and cancer: More importantly, we found that the expression level of Trop2 in CD44highCD24low cells was higher than that of non-CD44highCD24low cells, which might just explain the potential killing effect of hIMB1636-LDP-AE on cancer stem cells (Fig. 5h).